alesse
| Product dosage: 0.18mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 56 | $1.16 | $65.11 (0%) | 🛒 Add to cart |
| 84 | $1.06 | $97.66 $89.15 (9%) | 🛒 Add to cart |
| 112 | $1.01 | $130.21 $113.19 (13%) | 🛒 Add to cart |
| 168 | $0.96 | $195.32 $161.26 (17%) | 🛒 Add to cart |
| 224 | $0.93
Best per pill | $260.43 $208.34 (20%) | 🛒 Add to cart |
Synonyms | |||
Alesse is a combination oral contraceptive pill containing two synthetic hormones: ethinyl estradiol (an estrogen) and levonorgestrel (a progestin). It’s primarily prescribed for pregnancy prevention but has several important therapeutic applications beyond contraception. What’s interesting about Alesse in clinical practice isn’t just its mechanism—which we’ll get into—but how its specific hormone ratio makes it suitable for certain patient profiles where other options might be too androgenic or cause unwanted side effects. I’ve been prescribing this medication for over fifteen years, and the patterns I’ve observed often contradict what you’d expect from the textbook pharmacology.
1. Introduction: What is Alesse? Its Role in Modern Medicine
Alesse belongs to the category of monophasic combination oral contraceptives, meaning each active pill contains the same fixed dose of hormones (typically 20 mcg ethinyl estradiol and 0.1 mg levonorgestrel). While primarily known as a birth control pill, its applications extend to menstrual cycle regulation, acne management, and treatment of estrogen deficiency symptoms. Many patients initially seek Alesse specifically for contraception, but the therapeutic benefits for conditions like polycystic ovary syndrome (PCOS) and dysmenorrhea often become the more valued outcome long-term. The relatively low estrogen content compared to earlier generations makes it particularly suitable for patients sensitive to estrogen-related side effects.
2. Key Components and Bioavailability Alesse
The composition of Alesse includes ethinyl estradiol as the estrogen component and levonorgestrel as the progestin. Ethinyl estradiol is a synthetic estrogen with approximately 100 times the potency of natural estradiol due to the ethinyl group at C17, which significantly reduces first-pass metabolism and extends half-life. Levonorgestrel is a second-generation progestin derived from 19-nortestosterone, providing potent progestogenic activity with moderate androgenic effects.
Bioavailability considerations are crucial—ethinyl estradiol undergoes variable absorption and extensive gut wall and hepatic metabolism, while levonorgestrel is almost completely bioavailable after oral administration. The fixed combination in Alesse creates a predictable pharmacokinetic profile, though we do see considerable interindividual variation in ethinyl estradiol levels due to genetic polymorphisms in CYP3A4 and UGT enzymes. This explains why some patients experience breakthrough bleeding early in treatment while others don’t—it’s not just compliance issues but actual metabolic differences.
3. Mechanism of Action Alesse: Scientific Substantiation
Alesse works through multiple complementary mechanisms to prevent pregnancy, which is why its typical use failure rate remains below 1% with perfect use. The primary mechanism is suppression of the hypothalamic-pituitary-ovarian axis through negative feedback inhibition, specifically reducing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secretion. This prevents the follicular development and ovulation that would normally occur mid-cycle.
Secondary mechanisms include cervical mucus thickening—making it hostile to sperm penetration—and endometrial changes that create an unfavorable environment for implantation. The progestin component (levonorgestrel) is particularly effective at altering the cervical mucus consistency within hours of initiation, which is why we sometimes use it for emergency contraception at higher doses. For the endometrial effects, it typically takes about 2-3 cycles to establish the full atrophic changes that contribute to the contraceptive efficacy.
4. Indications for Use: What is Alesse Effective For?
Alesse for Pregnancy Prevention
As a combination oral contraceptive, Alesse is highly effective for preventing pregnancy when taken consistently. The Pearl Index ranges from 0.1-0.5 with perfect use, though typical use effectiveness drops to around 91% due to missed pills. The 20 mcg estrogen formulation provides sufficient ovulation suppression while minimizing estrogen-related side effects for most patients.
Alesse for Menstrual Regulation
For patients with irregular cycles, Alesse establishes predictable withdrawal bleeding and can significantly reduce menstrual blood loss. I’ve found it particularly helpful for adolescents with anovulatory cycles and perimenopausal women transitioning toward menopause who need cycle control.
Alesse for Acne Management
The anti-androgenic effect of the estrogen component combined with the relatively low androgenic activity of levonorgestrel makes Alesse moderately effective for hormonal acne. It works by reducing free testosterone levels through increased sex hormone-binding globulin (SHBG) production and directly inhibiting sebaceous gland activity.
Alesse for Polycystic Ovary Syndrome (PCOS)
While not FDA-approved specifically for PCOS, Alesse is commonly used off-label to regulate cycles, reduce hirsutism, and improve acne in PCOS patients. The cyclic progesterone withdrawal helps prevent endometrial hyperplasia that can occur with chronic anovulation.
Alesse for Premenstrual Dysphoric Disorder (PMDD)
For patients with significant premenstrual symptoms, the hormone stabilization provided by Alesse can reduce physical and emotional symptoms, though some patients actually do better with continuous dosing to eliminate the hormone fluctuations entirely.
5. Instructions for Use: Dosage and Course of Administration
Standard dosing follows a 28-day cycle: 21 active pills containing hormones followed by 7 placebo pills or a 7-day pill-free interval. Patients should take one pill daily at approximately the same time, with many preferring evening administration to sleep through potential nausea.
| Indication | Dosage | Frequency | Special Instructions |
|---|---|---|---|
| Contraception | 1 active pill | Daily for 21 days, then 7 placebo days | Start on first day of menstruation or Sunday after menstruation begins |
| Acne treatment | 1 active pill | Daily as per contraceptive schedule | Improvement typically seen after 3-6 months |
| Menstrual regulation | 1 active pill | Daily for 21 days, then 7 placebo days | Withdrawal bleeding expected during placebo week |
| Continuous cycling | 1 active pill | Daily without placebo breaks | For endometriosis or PMDD, skip placebo weeks as directed |
If a pill is missed (24-48 hours late), patients should take the missed pill immediately and continue regular schedule. If more than 48 hours late, additional contraception is needed for 7 days. For gastrointestinal disturbances with vomiting or diarrhea within 3-4 hours of ingestion, a backup method should be used.
6. Contraindications and Drug Interactions Alesse
Absolute contraindications include history of thromboembolic disorders, cerebrovascular or coronary artery disease, estrogen-dependent neoplasms, undiagnosed abnormal genital bleeding, hepatic dysfunction, pregnancy, and migraine with aura. Relative contraindications include hypertension, diabetes with vascular complications, smoking in women over 35, and hyperlipidemia.
Significant drug interactions occur with medications that induce hepatic enzymes, particularly CYP3A4 inducers:
- Anticonvulsants: Carbamazepine, phenytoin, phenobarbital reduce efficacy
- Antibiotics: Rifampin dramatically reduces hormone levels; other antibiotics have minimal effect
- Antiretrovirals: Nevirapine, ritonavir-containing regimens may reduce efficacy
- Herbal supplements: St. John’s Wort significantly reduces contraceptive hormone levels
I had a patient—Sarah, 28—who experienced breakthrough bleeding and ultimately contraceptive failure while on carbamazepine for trigeminal neuralgia, despite my clear warnings about the interaction. We’d discussed barrier methods as backup, but she admitted to inconsistent use. These real-world scenarios highlight how crucial it is to reinforce interaction warnings at every visit.
7. Clinical Studies and Evidence Base Alesse
The evidence for Alesse’s contraceptive efficacy comes from large-scale clinical trials like the 1999 European multicenter study published in Contraception, which followed over 1,600 women for up to 2 years. The study demonstrated a Pearl Index of 0.07 for method failure and 0.70 for user failure, confirming high efficacy with proper use.
For non-contraceptive benefits, a 2005 randomized controlled trial in the Journal of the American Academy of Dermatology showed significant improvement in inflammatory and non-inflammatory acne lesions compared to placebo, with 58% of patients showing at least 50% reduction in lesion count after 6 cycles.
Regarding safety profile, the 20 mcg estrogen formulation has demonstrated reduced risk of estrogen-related side effects while maintaining contraceptive efficacy. The EURAS study (European Active Surveillance Study) on cardiovascular risk found no increased risk of venous thromboembolism with levonorgestrel-containing COCs compared to non-hormonal methods after adjusting for confounders.
8. Comparing Alesse with Similar Products and Choosing a Quality Product
When comparing Alesse to other oral contraceptives, several factors distinguish it:
- Versus higher estrogen pills: Alesse’s 20 mcg estrogen content reduces bloating, breast tenderness, and nausea but may result in more breakthrough bleeding initially
- Versus progestin-only pills: Better cycle control and higher efficacy but with estrogen-related contraindications
- Versus third/fourth generation progestins: Lower risk of venous thromboembolism than desogestrel/drospirenone-containing pills but potentially less anti-androgenic benefit
Generic equivalents contain the same active ingredients but may have different inactive components that affect tolerability for some patients. Brand consistency can be important for patients who experience side effects with formulation changes.
9. Frequently Asked Questions (FAQ) about Alesse
How long does it take for Alesse to become effective as contraception?
If started within first 5 days of menstrual cycle, it’s effective immediately. Otherwise, backup contraception is needed for first 7 days.
Can Alesse cause weight gain?
Most studies show minimal average weight change, though individual responses vary due to fluid retention or increased appetite in some patients.
What should I do if I miss two pills?
Take two pills as soon as remembered, then two the next day, then resume regular schedule. Use backup contraception for 7 days.
Can Alesse be used for emergency contraception?
Not in its regular formulation—dedicated levonorgestrel emergency contraception contains higher single doses.
Does Alesse protect against sexually transmitted infections?
No—barrier methods are still necessary for STI prevention.
How long can I safely take Alesse?
Healthy non-smoking women can continue through menopause if no contraindications develop, with regular reassessment.
10. Conclusion: Validity of Alesse Use in Clinical Practice
Alesse remains a valid first-line option for combination oral contraception, particularly for patients who benefit from lower estrogen exposure or who experience side effects with higher-dose formulations. The risk-benefit profile favors use in appropriate candidates, with non-contraceptive benefits often enhancing adherence and overall satisfaction. Ongoing assessment of contraindications and potential interactions is essential for safe long-term management.
I remember when we first started using the lower-dose formulations back in the early 2000s—there was considerable debate among our practice group about whether the 20 mcg pills would provide sufficient cycle control. Dr. Williamson was convinced we’d see breakthrough bleeding rates that would make patients non-adherent, while I argued that the trade-off in reduced side effects would improve overall continuation. Turns out we were both partially right—about 15-20% of patients do experience more spotting in the first 3 months, but most stick with it because they feel better overall without the estrogen-heavy side effects.
One case that really shaped my approach was Maya, a 22-year-old law student who came in with debilitating menstrual migraines and moderately severe acne. She’d tried three different pills before seeing me, each time quitting due to mood changes or weight concerns. We started Alesse with continuous dosing to eliminate the hormone fluctuations that triggered her migraines. The first month was rough—she called twice about spotting and nausea—but by month three, her skin had cleared significantly and she’d had only one mild headache. At her six-month follow-up, she told me it was the first time since menarche that she hadn’t had to plan her life around her cycle. Those are the cases that remind you why we bother with the fine-tuning of hormone ratios and individual patient matching.
The unexpected finding I’ve observed over the years is that patients on Alesse seem to have better long-term adherence than some of the newer formulations, despite the theoretically higher breakthrough bleeding risk. I think there’s something to be said for starting with a well-tolerated, middle-of-the-road option rather than chasing the latest heavily marketed product. We recently reviewed our practice data from the past five years, and Alesse had the highest 12-month continuation rate of all our first-line OCs, which surprised some of the younger physicians who favor the newer progestins. Sometimes the older data holds clinical wisdom that doesn’t always show up in the controlled trials.